Le Lézard
Classified in: Covid-19 virus

Global Gold Potassium Cyanide Market (2020 to 2025) - Growth, Trends, and Forecast - ResearchAndMarkets.com


The "Gold Potassium Cyanide Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.

The market for gold potassium cyanide is expected to grow at a CAGR of more than 3% globally during the forecast period.

Increasing applications for electroplating of gold and growing demand from the electronic industry are driving the market growth. Highly toxic nature and the impact of COVID-19 are expected to hinder the market growth.

Companies Mentioned

Key Market Trends

Growing Demand from Electronic and Metal Plating Industries

Asia-Pacific Region to Dominate the Market

Key Topics Covered:

1 INTRODUCTION

1.1 Study Assumptions

1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Drivers

4.1.1 Increasing Applications for Electroplating of Gold

4.1.2 Growing Demand from the Electronics Industry

4.2 Restraints

4.2.1 High Toxic Nature and Impact of COVID-19

4.2.2 Other Restraints

4.3 Industry Value Chain Analysis

4.4 Porters Five Forces Analysis

5 MARKET SEGMENTATION

5.1 Applications

5.1.1 Electroplating of Metals

5.1.2 Decorative Costume Jewellery

5.1.3 Electronic Devices

5.1.4 Watches

5.1.5 Other Applications

5.2 Geography

5.2.1 Asia-Pacific

5.2.2 North America

5.2.3 Europe

5.2.4 South America

5.2.5 Middle-East and Africa

6 COMPETITIVE LANDSCAPE

6.1 Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements

6.2 Market Share/Ranking Analysis**

6.3 Strategies Adopted by Leading Players

6.4 Company Profiles

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

For more information about this report visit https://www.researchandmarkets.com/r/7v9m2a


These press releases may also interest you

at 02:30
Allied Market Research published a report, titled, "Pension Administration Software Market by Component (Solution and Services), Deployment Mode (On-Premise and Cloud), Type (Public Pension and Private Pension), End User (Employers, Pension Plan...

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood...

at 01:05
Teck Resources Limited (Teck) today announced its unaudited first quarter results for 2024. "All outstanding major construction at our QB operation was completed in the first quarter, including the shiploader and molybdenum plant, and we marked the...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter of 2024. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with...



News published on and distributed by: